These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15825922)

  • 1. Experience of colorectal cancer screening using a home-administered kit for fecal occult blood tests among a Chinese worksite population in Taiwan.
    Hou SI
    Psychol Rep; 2005 Feb; 96(1):178-80. PubMed ID: 15825922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Home-administered fecal occult blood test for colorectal cancer screening among worksites in Taiwan.
    Hou SI; Chen PH
    Prev Med; 2004 Jan; 38(1):78-84. PubMed ID: 14672644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer screening beliefs and reactions to an innovative colorectal cancer screening kit among Chinese worksite population.
    Hou S; Chen P
    Methods Inf Med; 2005; 44(2):315-8. PubMed ID: 15924199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing colorectal cancer screening in rural southern Taiwan.
    Lin YH; Kao CC
    Cancer Nurs; 2013; 36(4):284-91. PubMed ID: 22964866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with intentions for colorectal cancer screenings in a Chinese sample.
    Hou SI
    Psychol Rep; 2005 Feb; 96(1):159-62. PubMed ID: 15825919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer screening in LHU4 Chiavarese, Italy: ethical, methodological and outcome evaluations at the end of the first round.
    Ferrari Bravo M; De Conca V; Devoto GL; Sironi M; Mele R; Fumagalli A; Rimassa P; Rossi G; Zampogna A; Sticchi C; Gabutti G;
    J Prev Med Hyg; 2012 Mar; 53(1):37-43. PubMed ID: 22803318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening.
    Almog R; Ezra G; Lavi I; Rennert G; Hagoel L
    Eur J Cancer Prev; 2008 Oct; 17(5):430-7. PubMed ID: 18714185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient perceptions of stool-based DNA testing for colorectal cancer screening.
    Schroy PC; Heeren TC
    Am J Prev Med; 2005 Feb; 28(2):208-14. PubMed ID: 15710277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal occult blood testing instructions and impact on patient adherence.
    Bapuji SB; Lobchuk MM; McClement SE; Sisler JJ; Katz A; Martens P
    Cancer Epidemiol; 2012 Aug; 36(4):e258-64. PubMed ID: 22504053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: a randomized, controlled trial.
    Hoffman RM; Steel S; Yee EF; Massie L; Schrader RM; Murata GH
    Prev Med; 2010; 50(5-6):297-9. PubMed ID: 20307568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manipulating perceptions of colorectal cancer threat: implications for screening intentions and behaviors.
    Lipkus IM; Green LG; Marcus A
    J Health Commun; 2003; 8(3):213-28. PubMed ID: 12857652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the long-term effect of FOBT in colorectal cancer screening.
    Luo D; Cambon AC; Wu D
    Cancer Epidemiol; 2012 Feb; 36(1):e54-60. PubMed ID: 22075536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal occult blood testing for colorectal cancer in an ethnically diverse population.
    Glober GA; Hundahl S; Stucke J; Choy M
    West J Med; 1994 Oct; 161(4):377-82. PubMed ID: 7817548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
    Quintero E
    Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Smith A; Young GP; Cole SR; Bampton P
    Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tailored navigation in colorectal cancer screening.
    Myers RE; Hyslop T; Sifri R; Bittner-Fagan H; Katurakes NC; Cocroft J; Dicarlo M; Wolf T
    Med Care; 2008 Sep; 46(9 Suppl 1):S123-31. PubMed ID: 18725824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "It's a small price to pay for life": faecal occult blood test (FOBT) screening for colorectal cancer, perceived barriers and facilitators.
    Reeder AI
    N Z Med J; 2011 Mar; 124(1331):11-7. PubMed ID: 21725408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.